Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Lee HJ et al. | 2012 | intact cell/cell culture, NIH3T3 cells (mouse fibroblasts), normal and transfected with a c-Myc-containing vector or with an empty vetor | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
| Lee HM et al. | 2010 | intact cell/cell culture, human intervertebral disc cells | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 1.8 mT |
| Lee YJ et al. | 2016 | intact cell/cell culture, CD4<sup>+</sup> T cells derived from mice (C57/BL6 mice and Foxp3-GFP mice) | magnetic field, 50/60 Hz | 0.3 mT |
| Lekovic MH et al. | 2020 | intact cell/cell culture, MRC-5 (human diploid fibroblasts) | 50/60 Hz, magnetic field | 10 mT |
| Leone L et al. | 2014 | intact cell/cell culture, neural stem cells from newborn mice, animal, mouse/C57bl/6, whole body | magnetic field, 50/60 Hz | 1 mT |
| Li X et al. | 2012 | intact cell/cell culture, mesenchymal bone marrow stem cells (from femurae and tibiae of Sprague-Dawley rats) | magnetic field, signals/pulses, 50/60 Hz | 10 mT |
| Li X et al. | 2019 | animal, mouse/C57BL/6 | magnetic field, 50/60 Hz | 5 mT |
| Li Y et al. | 2014 | intact cell/cell culture, culture medium, K562 and HEL 92.1.7 cells (human erythroleukemic cell lines), MCF-7 cells (human breast cancer cell line), NCI-H460 cells (human lung cancer cell line), Colo 320 DM cells (human colon carcinoma cell line) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 4 nT–74 µT |
| Liburdy RP et al. | 1993 | intact cell/cell culture, MCF-7 cells (melatonin-sensitive breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 0.19–1.195 µT |
| Liu C et al. | 2013 | intact cell/cell culture, rat bone marrow mesenchymal stromal cells | magnetic field, 50/60 Hz | 1 mT |
| Livingston GK et al. | 1991 | intact cell/cell culture, human peripheral blood lymphocytes and Chinese hamster ovary (CHO) cells | magnetic field, 50/60 Hz, electric current application | 0.22 mT |
| Loberg LI et al. | 2000 | intact cell/cell culture, <i>Ataxia telangiectasia</i> and normal human lymphoblastoid cell lines | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Loberg LI et al. | 2000 | intact cell/cell culture, MCF-7, ZR-75-1, T-47D, and MDA-MB-231 (breast cancer cell line) and normal human breast epithalial cells | magnetic field, 50/60 Hz | 1 mT |
| Lucia U et al. | 2017 | - | low frequency, magnetic field, 50/60 Hz, theoretical/in silico study | - |
| Luukkonen J et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Ma Q et al. | 2014 | intact cell/cell culture, embryonic neural stem cells (mouse/BALB/c) | magnetic field, 50/60 Hz | 0.5–2 mT |
| Ma Q et al. | 2016 | intact cell/cell culture, embryonic neural stem cells (mouse/BALB/c) | magnetic field, 50/60 Hz | 1 mT |
| Mahmoudinasab H et al. | 2018 | - | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Mannerling AC et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 0.025–0.1 mT |
| Manni V et al. | 2002 | intact cell/cell culture, HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz | 2 mT |
| Manni V et al. | 2004 | intact cell/cell culture, human oral keratinocytes | magnetic field, 50/60 Hz | 2 mT |
| Marcantonio P et al. | 2010 | intact cell/cell culture, BE(2)C cells (human neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz, co-exposure | 1 mT |
| Markowska-Szczupak A et al. | 2022 | bacterium, <i>Escherichia coli</i>/K12 | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Martinez MA et al. | 2012 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz | 100 µT |
| Martinez MA et al. | 2016 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Martínez MA et al. | 2019 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | 50/60 Hz, magnetic field | 100 µT |
| McFarlane EH et al. | 2000 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz | 4.35–15.8 µT |
| Mevissen M et al. | 1996 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, co-exposure | 50 µT |
| Miyakoshi J et al. | 1994 | intact cell/cell culture, human leukemia cell lines (HL60RG, CCRF-CEM9), GM0637 cells (normal human fibroblast cell line), TAT2SF cells (human Louis-Bar syndrome fibroblast cell line) | magnetic field, 50/60 Hz, also other exposures without EMF | 400 mT |
| Miyakoshi J et al. | 1996 | intact cell/cell culture, CHO (Chinese hamster ovary) cells | magnetic field, 50/60 Hz | 5 mT |
| Morabito C et al. | 2010 | intact cell/cell culture, PC-12 cells | magnetic field, low frequency, 50/60 Hz | 0.1–1 mT |
| Morabito C et al. | 2017 | - | magnetic field, 50/60 Hz | - |
| Moraveji M et al. | 2021 | intact cell/cell culture, rat adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, signals/pulses, also other exposures without EMF, co-exposure | - |
| Moya-Gómez A et al. | 2023 | intact cell/cell culture, BV2 cells (immortalized murine microglial cell line), SHSY5Y cells, (immortalized human neuroblastoma cell line), primary mouse microglia and neurons, animal, mongolian gerbils <i>(Meriones unguiculatus)</i> (stroke model) | 50/60 Hz, magnetic field | - |
| Naarala J et al. | 2017 | intact cell/cell culture, human umbilical vein endothelial cells (HUVEC), C6 cells (rat glioma cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, shielding/field deprivation | 0.2–120 µT |
| Nafziger J et al. | 1997 | intact cell/cell culture, human bone marrow cells | magnetic field, 50/60 Hz | 10 µT–1 mT |
| Naghibzadeh M et al. | 2020 | intact cell/cell culture, human dermal fibroblasts | magnetic field, 50/60 Hz | 1–5 mT |
| Nascimento LF et al. | 2003 | bacterium, <i>Escherichia coli</i>/ATCC 25922 | magnetic field, 50/60 Hz | 500 µT |
| Nasrabadi N et al. | 2018 | intact cell/cell culture, human retinal pigment epithelial cells | 50/60 Hz, signals/pulses, magnetic field | 1 mT |
| Nawrotek P et al. | 2014 | bacterium, <i>Escherichia coli</i>/O157:H7 and E68II/0141 and <i>Staphylococcus aureus</i>/FRI 913, ATCC 25923 and ATCC 43300 | magnetic field, 50/60 Hz | 30 mT |
| Nindl G et al. | 1997 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, signals/pulses, 50/60 Hz | 0.1–1.8 mT |
| Novak J et al. | 2007 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | magnetic field, 50/60 Hz | 5.2–10 mT |
| Nurković J et al. | 2017 | - | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
| Oladnabi M et al. | 2019 | - | magnetic field, signals/pulses, 50/60 Hz | - |
| Oncul S et al. | 2016 | bacterium, <i>Escherichia coli, Staphylococcus aureus</i> | magnetic field, 50/60 Hz | - |
| Ozlem-Caliskan S et al. | 2016 | - | magnetic field, 50/60 Hz, signals/pulses | - |
| Paile W et al. | 1995 | intact cell/cell culture, human peripheral blood lymphocytes and human peripheral whole blood | magnetic field, signals/pulses, 50/60 Hz, occupational | 30 µT–1 mT |
| Pang L et al. | 2002 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 4.4–13 mT |
| Paradisi S et al. | 1993 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 2.5 mT |
| Parola AH et al. | 2005 | intact cell/cell culture, embryonic chicken fibroblasts, plant, duckweed (<i>Spirodela oligorrhiza</i>) | magnetic field, 50/60 Hz, co-exposure | 0.7 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
